Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Metacognitive Therapy vs Cognitive-Behavioral Therapy for Anxiety Disorders

Official title: Transdiagnostic Metacognitive Therapy Compared to Disorder-specific Cognitive-behavioral Therapy for Anxiety Disorders: a Qualitative Study

Run by Karolinska Institutet · NCT07382323 · Data updated 2026-11-12

This study asks people with generalized anxiety disorder, social anxiety disorder, or PTSD to share their experiences after trying metacognitive therapy or disorder-specific cognitive-behavioral therapy in a randomized trial.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations1 site (Stockholm)
StatusRecruiting
StartedJanuary 28, 2026
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedAugust 18, 2026
Trial IDNCT07382323 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18+ with a principal diagnosis of generalized anxiety disorder, social anxiety disorder, or PTSD who previously participated in the randomized trial and can speak/read Swedish.

Probably not a fit

Patients who did not participate in the prior trial or who do not speak Swedish may not benefit from the findings of this qualitative study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This qualitative study examines participants’ perceptions of two anxiety-focused treatments: transdiagnostic metacognitive therapy and disorder-specific cognitive-behavioral therapy. It draws on participants who previously enrolled in a randomized controlled trial to understand factors affecting implementation and dissemination. The goal is to identify barriers, facilitators, and overall acceptability to inform future adoption in clinical settings. Methods involve qualitative data collection from trial participants to contextualize treatment experiences and preferences. The study is led by Karolinska Institutet at the Northern Stockholm Psychiatry Clinic in Sweden.

Why it matters

Potential benefit: Findings could help clinicians tailor anxiety treatments and improve how these therapies are offered to patients in routine care.

How similar studies have gone: Earlier trials have used qualitative methods to understand patient experiences with cognitive-behavioral approaches, supporting the value of this exploratory angle.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older,
* A principal diagnosis of generalized anxiety disorder, social anxiety disorder, or posttraumatic stress disorder,
* No change in dose during the last six weeks if on pharmacological treatment, and
* Ability to read and speak Swedish.

Exclusion Criteria:

* A current diagnosis of psychotic disorder, bipolar disorder, neurocognitive disorder, or moderate to severe substance use disorder,
* Acute suicide risk, or
* Concurrent psychological treatment.

Where it's running

  • Northern Stockholm Psychiatry Clinic
    Stockholm, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.